K

S

Stata Venture Partners

Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Seed

F
Foundation EGI

Biotechnology • Bispecific antibodies

Bambusa Therapeutics Inc. develops bispecific antibodies for treating immunological and inflammatory disorders.

Seed
$7.6M
04/17/2025
Article